Abstract 023
| Centres (%) | UK | International |
|---|---|---|
| Pre-ablation | ||
| Warfarin | ||
| All patients/conventional indication | 100 | 100 |
| Heparin | ||
| All patients/conventional indication | 50–53 | 86 |
| TOE | ||
| All patients/conventional indication | 50–53 | 100 |
| Target TCT(s) | ||
| >350 | 0 | 17 |
| 300–350 | 60 | 66 |
| 200–250 | 33 | 0 |
| Not checked | 7 | 17 |
| Post-ablation | ||
| Warfarin | ||
| All patients/conventional indication | 97–100 | 100 |
| Heparin | ||
| All patients/conventional indication | 77–83 | 86 |